NEOGAP Therapeutics

NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Domain

neogap.se

Country

Sweden

Employees

11-50

Last Funding

$9.8M

Founded

2015

Frequently Asked Questions

What technologies does NEOGAP Therapeutics use?+

NEOGAP Therapeutics uses 24 technologies including Elementor, Font Awesome, Google Analytics.

What industry is NEOGAP Therapeutics in?+

NEOGAP Therapeutics operates in the Biotechnology industry.

Where is NEOGAP Therapeutics based?+

NEOGAP Therapeutics is headquartered in Sweden.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026